Celldex Therapeutics (CLDX) Revenue (2010 - 2026)
Celldex Therapeutics (CLDX) reported Revenue of $22,000 for Q2 2026, down 97.0% from $730,000 a year earlier but up 46.7% from the prior quarter.
Powered by 
Analysis
Celldex Therapeutics (CLDX) Revenue (2010 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, Celldex Therapeutics' Revenue came in at $158,000, down 97.3% year-over-year; for FY2025, it came in at $1.55 million, down 78.0% from FY2024.
- Revenue has a five-year compound annual growth rate of -26.9% (FY2020 to FY2025).
- By year, Revenue came in at $7.02 million in FY2024 (+2.0%), $6.88 million in FY2023 (+192.0%), $2.36 million in FY2022 (-49.3%) and $4.65 million in FY2021 (-37.3%).
- Five-year quarterly Revenue spans a low of $15,000 in Q1 2026 and a high of $4.13 million in Q4 2023.
- Year over year, Revenue has now declined in each of the last three quarters, with growth averaging 4.1% over the last seven quarters.
- The high point for year-over-year Revenue in five years was Q2 2024 (growth of 832.1%); the low point was Q1 2026 (a decline of 97.8%).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,144.36 Bn | 1,112.95 Bn | 19.71 Bn | 22.97 Bn |
| 2 | Johnson & Johnson | 635.36 Bn | 555.22 Bn | 17.30 Bn | 25.40 Bn |
| 3 | AbbVie | 502.79 Bn | 475.90 Bn | 12.70 Bn | 16.99 Bn |
| 4 | Merck | 356.08 Bn | 310.46 Bn | 12.21 Bn | 16.61 Bn |
| 5 | Novartis Ag | 300.87 Bn | 264.86 Bn | 11.24 Bn | 14.41 Bn |
| 6 | Astrazeneca | 264.31 Bn | 237.99 Bn | 12.86 Bn | 15.38 Bn |
| 7 | Amgen | 239.07 Bn | 194.47 Bn | 7.24 Bn | 10.05 Bn |
| 8 | Gilead Sciences | 194.50 Bn | 168.70 Bn | 6.22 Bn | 7.80 Bn |
| 9 | Pfizer | 171.00 Bn | 117.64 Bn | 10.94 Bn | 15.03 Bn |
| 10 | Celldex Therapeutics | 2.23 Bn | -39.17 Mn | - | 22,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 22,000.00 |
| Mar 31, 2026 | 15,000.00 |
| Dec 31, 2025 | 121,000.00 |
| Jun 30, 2025 | 730,000.00 |
| Mar 31, 2025 | 695,000.00 |
| Dec 31, 2024 | 1.18 Mn |
| Sep 30, 2024 | 3.19 Mn |
| Jun 30, 2024 | 2.50 Mn |
| Mar 31, 2024 | 156,000.00 |
| Dec 31, 2023 | 4.13 Mn |
| Sep 30, 2023 | 1.52 Mn |
| Jun 30, 2023 | 268,000.00 |
| Mar 31, 2023 | 967,000.00 |
| Dec 31, 2022 | 1.61 Mn |
| Sep 30, 2022 | 407,000.00 |
| Jun 30, 2022 | 163,000.00 |
| Mar 31, 2022 | 174,000.00 |
| Dec 31, 2021 | 334,000.00 |
| Sep 30, 2021 | 153,000.00 |
| Jun 30, 2021 | 3.48 Mn |
API Access
Celldex Therapeutics Revenue API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=revenue&ticker=CLDX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "revenue", "ticker": "CLDX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=revenue&ticker=CLDX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();